Structures by: Khandavilli U. B.
Total: 29
Gamma-hydroxy-beta-lactam, methyl cyclohexyl derivative
C19H27NO2
Organic letters (2016) 18, 19 4978-4981
a=11.0767(3)Å b=6.1023(2)Å c=13.1637(4)Å
α=90° β=104.8480(10)° γ=90°
C19H21NO2
C19H21NO2
Organic letters (2016) 18, 19 4978-4981
a=5.3836(3)Å b=31.775(2)Å c=9.5511(6)Å
α=90° β=90° γ=90°
C19H23N3O5
C19H23N3O5
Organic & biomolecular chemistry (2020) 18, 3 557-568
a=6.8732(3)Å b=16.6383(7)Å c=16.3749(7)Å
α=90° β=91.7080(10)° γ=90°
4'-(4-nitrophenyl)spiro[indene-2,5'-[1,4,2]oxathiazol]-1(3H)-one-4'-oxide
C16H10N2O5S
Organic & biomolecular chemistry (2019) 17, 3 622-638
a=7.5520(11)Å b=8.2283(11)Å c=12.8010(18)Å
α=74.726(4)° β=86.674(5)° γ=72.819(4)°
C20H19NO3S
C20H19NO3S
Organic & biomolecular chemistry (2019) 17, 3 622-638
a=11.0131(2)Å b=11.9246(2)Å c=14.5681(3)Å
α=90° β=107.1060(10)° γ=90°
C17H12FNO3S
C17H12FNO3S
Organic & biomolecular chemistry (2019) 17, 3 622-638
a=15.237(3)Å b=11.212(2)Å c=17.948(3)Å
α=90° β=90° γ=90°
C16H11NO3S
C16H11NO3S
Organic & biomolecular chemistry (2019) 17, 3 622-638
a=7.342(2)Å b=8.954(3)Å c=11.714(3)Å
α=70.226(9)° β=83.607(9)° γ=72.230(9)°
C9H18NO4
C9H18NO4
CrystEngComm (2020) 22, 3 412-415
a=11.7250(10)Å b=6.1271(4)Å c=16.0527(15)Å
α=90° β=99.628(9)° γ=90°
C15H23NO5
C15H23NO5
CrystEngComm (2020) 22, 3 412-415
a=30.706(2)Å b=9.6913(7)Å c=11.0426(9)Å
α=90° β=90° γ=90°
C18H36N2O8
C18H36N2O8
CrystEngComm (2020) 22, 3 412-415
a=11.5328(10)Å b=6.1123(5)Å c=16.0138(14)Å
α=90° β=99.780(9)° γ=90°
C15H23NO5
C15H23NO5
CrystEngComm (2020) 22, 3 412-415
a=9.5719(7)Å b=30.798(2)Å c=10.9331(9)Å
α=90° β=90° γ=90°
Hydrate of 1:1 cocrystal of Temozolomide and Formic acid
2(C6H6N6O2),CH4O3
CrystEngComm (2013) 15, 4 666
a=8.173(12)Å b=11.626(17)Å c=11.735(17)Å
α=64.73(2)° β=74.09(3)° γ=89.31(3)°
C6H7N6O2,C6H6N6O2,2(Cl),H3O,3(H2O
C6H7N6O2,C6H6N6O2,2(Cl),H3O,3(H2O
CrystEngComm (2013) 15, 4 666
a=6.453(15)Å b=10.37(2)Å c=17.84(4)Å
α=97.80(4)° β=90.44(4)° γ=98.27(4)°
C16H9F2NO2S
C16H9F2NO2S
Organic & biomolecular chemistry (2019) 17, 3 622-638
a=14.0083(10)Å b=8.7108(6)Å c=11.5419(8)Å
α=90° β=105.733(2)° γ=90°
Glibenclamide
C23H28ClN3O5S
CrystEngComm (2017) 19, 6 918
a=9.45444(13)Å b=17.6795(3)Å c=14.4839(2)Å
α=90° β=93.4373(13)° γ=90°
Glibenclamidesodium salt
C23H27ClN3NaO5S
CrystEngComm (2017) 19, 6 918
a=10.9425(10)Å b=10.1583(7)Å c=11.5023(11)Å
α=90° β=91.164(9)° γ=90°
Glibenclamide-sodiumhydrate salt
C23H27ClN3NaO6S
CrystEngComm (2017) 19, 6 918
a=19.5991(16)Å b=5.8086(3)Å c=23.4722(17)Å
α=90° β=108.746(8)° γ=90°
Glibenclamide-ammonium salt
C23H31ClN4O5S
CrystEngComm (2017) 19, 6 918
a=19.718(4)Å b=6.1475(11)Å c=21.732(5)Å
α=90° β=109.25(2)° γ=90°
Glibenclamide-potassium salt
C23H27ClKN3O5S
CrystEngComm (2017) 19, 6 918
a=19.819(4)Å b=6.2006(9)Å c=21.636(5)Å
α=90° β=109.69(2)° γ=90°
Glibenclamidesodium salt
C23H27ClN3NaO5S
CrystEngComm (2017) 19, 6 918
a=19.7594(13)Å b=6.1759(3)Å c=21.5560(15)Å
α=90° β=109.627(7)° γ=90°
Clotrimazole-2,5-Dihydroxybenzoic acid
C22H18ClN2,C7H5O4
Crystal Growth & Design (2015) 15, 5 2493
a=10.1762(10)Å b=10.6463(8)Å c=13.0417(9)Å
α=108.469(7)° β=102.963(8)° γ=107.069(8)°
Clotrimazole-Caffeic acid-anisole
C23H17ClN2,C9H7O4,C7H8O
Crystal Growth & Design (2015) 15, 5 2493
a=12.4974(17)Å b=14.527(2)Å c=17.789(2)Å
α=90.00° β=96.028(2)° γ=90.00°
Clotrimazole-2,4,6-Trihydroxybenzoic acid
C22H18ClN2,C7H5O5
Crystal Growth & Design (2015) 15, 5 2493
a=12.0214(14)Å b=13.8128(16)Å c=15.9926(18)Å
α=90.00° β=97.934(2)° γ=90.00°
Clotrimazole-Adipic acid
C22H17ClN2,0.5(C6H10O4)
Crystal Growth & Design (2015) 15, 5 2493
a=8.7300(9)Å b=9.6543(9)Å c=13.2542(13)Å
α=74.480(9)° β=84.281(8)° γ=85.466(8)°
Clotrimazole-p-Coumaric acid
C22H18ClN2,C9H7O3
Crystal Growth & Design (2015) 15, 5 2493
a=10.3536(13)Å b=14.9452(14)Å c=16.4976(19)Å
α=90.00° β=90.00° γ=90.00°
C27H26O9
C27H26O9
Crystal Growth & Design (2011) 11, 9 4135
a=7.3706(6)Å b=15.8001(10)Å c=19.8972(14)Å
α=90.00° β=92.933(7)° γ=90.00°
C27H26O8
C27H26O8
Crystal Growth & Design (2011) 11, 9 4135
a=7.7321(9)Å b=16.1990(19)Å c=19.558(3)Å
α=90.00° β=101.095(12)° γ=90.00°